| 1 |
Boyd P, Merkatz R, Variano B, Malcolm RK. The ins and outs of drug-releasing vaginal rings: a literature review of expulsions and removals. Expert Opinion on Drug Delivery 2020;17:1519-40. [DOI: 10.1080/17425247.2020.1798927] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Abdelkader H, Fathalla Z, Seyfoddin A, Farahani M, Thrimawithana T, Allahham A, Alani AWG, Al-Kinani AA, Alany RG. Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants. Adv Drug Deliv Rev 2021;177:113957. [PMID: 34481032 DOI: 10.1016/j.addr.2021.113957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Tiboni M, Campana R, Frangipani E, Casettari L. 3D printed clotrimazole intravaginal ring for the treatment of recurrent vaginal candidiasis. International Journal of Pharmaceutics 2021;596:120290. [DOI: 10.1016/j.ijpharm.2021.120290] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 4 |
Abd Ellah NH, Shaltout AS, Abd El Aziz SMM, Abbas AM, Abd El Moneem HG, Youness EM, Arief AF, Ali MF, Abd El-Hamid BN. Vaginal suppositories of cumin seeds essential oil for treatment of vaginal candidiasis: Formulation, in vitro, in vivo, and clinical evaluation. Eur J Pharm Sci 2021;157:105602. [PMID: 33086117 DOI: 10.1016/j.ejps.2020.105602] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Murphy DJ, Lim D, Armstrong R, McCoy CF, Bashi YHD, Boyd P, Derrick T, Spence P, Devlin B, Malcolm RK. Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance. Drug Deliv Transl Res 2021. [PMID: 34674162 DOI: 10.1007/s13346-021-01081-7] [Reference Citation Analysis]
|
| 6 |
Tian C, Jie H, Xia M, Liu Liu, Cao W, Chen J, Xiaoqin C. Physicochemical Evaluation and Pharmacodynamics of Itraconazole-loaded Liquid Crystal Precursor for Vaginal Delivery. Drug Dev Ind Pharm 2021;:1-19. [PMID: 34779328 DOI: 10.1080/03639045.2021.1988096] [Reference Citation Analysis]
|
| 7 |
Zhou Z. Co-drug delivery of regorafenib and cisplatin with amphiphilic copolymer nanoparticles: enhanced in vivo antitumor cancer therapy in nursing care. Drug Deliv 2020;27:1319-28. [PMID: 32936009 DOI: 10.1080/10717544.2020.1815897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Rafiei F, Tabesh H, Farzad S, Farzaneh F, Rezaei M, Hosseinzade F, Mottaghy K. Development of Hormonal Intravaginal Rings: Technology and Challenges. Geburtshilfe Frauenheilkd 2021;81:789-806. [PMID: 34276064 DOI: 10.1055/a-1369-9395] [Reference Citation Analysis]
|
| 9 |
Tosca EM, Rocchetti M, Pérez E, Nieto C, Bettica P, Moscoso Del Prado J, Magni P, De Nicolao G. In Vitro-In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone. Pharmaceutics 2021;13:255. [PMID: 33673306 DOI: 10.3390/pharmaceutics13020255] [Reference Citation Analysis]
|
| 10 |
Carson L, Merkatz R, Martinelli E, Boyd P, Variano B, Sallent T, Malcolm RK. The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings. Pharmaceutics 2021;13:751. [PMID: 34069590 DOI: 10.3390/pharmaceutics13050751] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
